Paul Little

Paul Little has a diverse work experience in the biopharmaceutical industry. Paul has worked as an Operating Partner at Lundbeckfonden/Lundbeck Foundation since April 2022, and previously held the same position from January 2018 to April 2022. Prior to that, Paul was an Associate at the same company from September 2015 to December 2017. Paul has also served as a Board Director at FOLIUM Science since December 2018. For Vesper Bio ApS, Paul held the position of CEO from October 2018. Paul worked as a VP CMC at CytoKi Pharma from June 2019 to June 2021. At Insusense ApS, they were the Senior Vice President, CMC from June 2014 to September 2018. From June 2016 to October 2017, Paul was the COO at NMD Pharma ApS. Paul also has experience as the Director of CMC & Preclinical Development at Orphazyme ApS from August 2011 to May 2014. At 7TM Pharma A/S, they held various roles including Director of Chemistry, Manufacturing & Controls from June 2008 to June 2012, and Senior Chemist from July 2001 to June 2008. Paul's earlier work experience includes serving as an Experimental Officer in postdoctoral research from January 1998 to January 2001.

Paul Little pursued their education at various institutions. Paul completed their Bachelor of Science degree in Chemistry from the University of Nottingham in 1995. In the same year, they also obtained their Ph.D. in Organic Chemistry from Cardiff University / Prifysgol Caerdydd. Prior to that, they attended Worksop College from 1987 to 1992.

In addition to their formal education, Paul Little has obtained various certifications. Paul is a Fellow Chartered Chemist of the Royal Society of Chemistry since December 2021. Paul has also obtained certifications such as Gut Check: Exploring Your Microbiome from Coursera Verified Certificates and holds designations such as Chartered Chemist and Chartered Scientist.